Track the Apotea AB (publ) stock price and the full directors' dealings record of the company, a listed equity based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Apotea AB (publ) has logged 5 public disclosures. Market capitalisation: €7.8bn. The latest transaction was disclosed on 1 June 2026 (Purchase). Among the most active insiders: Stefan Eriksson. Every trade is free.
5
Insider Decl.
0
Thresholds
€49,047
4 ops.
Buy Volume
·
0 ops.
Sell Volume
31Σ signal
Buys €49,047· Sells
Fundamental score
Ranked 12,959 of 25,921 companies
52.0
score / 100
Value
42
Quality
62
FCF yld1.5%
Earn yld2.9%
EV/EBITDA17.4x
ROE28%
Gross mgn27%
Net mgn3.2%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.